| Financial Year |
March 31 2023 |
| Monetary Funds |
151,803,908,608.25 |
| Held-for-trading Financial Assets |
129,742,707.28 |
| Notes Receivable |
1,913,370.65 |
| Accounts Receivable |
4,532,277,144.02 |
| Advances to Suppliers |
25,778,466,849.54 |
| Other Receivables |
152,679,406,166.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
16,456,849.02 |
| Inventories |
877,252,435,684.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,359,925,499.31 |
| Total Current Assets |
1,274,978,493,114.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
107,940,382,963.05 |
| Investment Properties |
30,643,267,042.56 |
| Fixed Assetes |
10,057,609,826.28 |
| Under-construction Projects |
576,707,955.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
360,527,394.42 |
| R&D expenses |
-- |
| Goodwill |
66,824,058.16 |
| Long-Term Deferred and Prepaid Expenses |
344,320,254.30 |
| Deferred Income Tax Assets |
14,566,118,631.19 |
| Other Non-Current Assets |
1,577,369.42 |
| Sub-Total of Non-Current Assets |
173,046,239,167.89 |
| Total Assets |
1,448,024,732,282.77 |
| Short-Term Loans |
1,080,083,400.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
103,742,245.50 |
| Accounts Payable |
141,576,005,051.28 |
| Accounts Received In Advance |
904,028,456.62 |
| Employee Compensation Payable |
503,973,241.31 |
| Taxes Payable |
6,574,082,901.75 |
| Interest Payable |
-- |
| Dividend Payable |
79,035,436.53 |
| Other payables |
116,835,597,264.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
68,373,840,500.83 |
| Other Current Liabilities |
43,597,818,544.77 |
| Sub-Total of Current Liabilities |
819,663,043,885.55 |
| Long-term Loans |
242,683,257,984.70 |
| Bonds Payable |
58,338,124,694.43 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,778,662,641.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
307,675,187,335.53 |
| Total Liabilities |
1,127,338,231,221.08 |
| Paid-In Capital(Or Share Stock) |
11,970,443,418.00 |
| Capital Surplus |
17,685,405,918.13 |
| Surplus Reserve |
6,074,373,454.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
154,239,249,750.45 |
| Minority Stockholder's Interest |
122,627,765,209.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
198,058,735,851.80 |
| Owner's Equity（Stockholder's Equity） |
320,686,501,061.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,448,024,732,282.77 |
